A recent study compared two dosages of ifinatamab deruxtecan among patients with extensive-stage small cell lung cancer.

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

A new study demonstrates that the combination of lenalidomide (Revlimid) and obinutuzumab (Gazyva) is effective and ...

The recent rate cuts from the Federal Reserve are poised to create a ripple effect across the financial sector, particularly ...

Debt/EBITDA ratios are vital to estimate a firm’s capability to pay off incurred debt—specifically to examine the default ...

As the S&P 500 index has remained flat, Sempra shares have rallied in the past two months. Read my latest analysis on ...

Nevada Department of Education has announced the performance results from the 2023-24 school year, including scores that ...

"Free-riding cash is going to be going away," said Brendan McCarthy, global head of ETF distribution at Goldman Sachs Asset Management, in a phone interview. "Now that the Fed is easing, people are ...

Western Asset Inv Grade Income Fund Inc is a stable pick for long-term investors with sustainable distributions and solid ...

The Federal Reserve’s Sept. 18 rate cut, the first time in more than four years, means the central bank has pivoted and ...

Boston College HC BIll O’Brien has turned around the program in short order, grinding out games with a punishing 81% run rate ...

This piece presents some difficult questions as to the relevancy of credit analysis in an increasingly AI and data driven market.